Home pageSTAR • NSE
add
Strides Pharma Science Ltd
Chiusura precedente
883,75 ₹
Intervallo giornaliero
870,55 ₹ - 895,65 ₹
Intervallo annuale
432,26 ₹ - 914,00 ₹
Cap di mercato
81,69Â Mld INR
Volume medio
784.063,00
Rapporto P/E
20,01
Dividendo/Prezzo
-
Borsa valori principale
NSE
Notizie del mercato finanziario
Dati finanziari
Conto economico
Entrate
Utile netto
(INR) | mar 2025info | Variazione Y/Y |
---|---|---|
Entrate | 11,90Â Mld | 9,81% |
Spese di gestione | 5,22Â Mld | 60,06% |
Utile netto | 821,94Â Mln | 352,24% |
Margine di profitto netto | 6,90 | 310,71% |
Utili per azione | — | — |
EBITDA | 2,17Â Mld | 0,42% |
Aliquota fiscale effettiva | 19,51% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(INR) | mar 2025info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 2,06Â Mld | -28,76% |
Totale attivo | 60,49Â Mld | 3,58% |
Totale passivo | 34,62Â Mld | -8,12% |
Patrimonio netto totale | 25,86 Mld | — |
Azioni in circolazione | 92,15 Mln | — |
Prezzo/valore contabile | 3,19 | — |
Redditività dell'attivo | — | — |
Rendimento sul capitale | 9,40% | — |
Flusso di cassa
Flusso di cassa netto
(INR) | mar 2025info | Variazione Y/Y |
---|---|---|
Utile netto | 821,94Â Mln | 352,24% |
Liquidità di esercizio | — | — |
Contanti da investimenti | — | — |
Contanti da finanziamenti | — | — |
Flusso di cassa netto | — | — |
Flusso di cassa libero | — | — |
Informazioni
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Fondazione
1990
Sito web
Dipendenti
3.065